Assure to Attend Investor Conferences in May and June 2022
DENVER, May 17, 2022 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (NASDAQ: IONM), a provider of intraoperative neuromonitoring (“IONM”) and remote neurology services, announced that management will participate in the following investor conferences in May and June 2022:
- MicroCap Rodeo Spring Into Action Conference May 16-20, 2022. Qualified institutional investors recommended each of the 36 companies represented as one of their best ideas. Assure’s executive chairman and CEO John Farlinger is scheduled to present on May 18th at 2:30 p.m. ET with one-on-one meetings held throughout the conference. To receive additional information, request an invitation, or to schedule a one-on-one meeting, please email email@example.com. Register for the webcast here: https://www.webcaster4.com/Webcast/Page/2882/45571
- The Benchmark Company’s Healthcare House Call Conference June 2, 2022. The event will be showcasing dynamic publicly traded micro-cap healthcare companies. Management will participate in one-on-one investor meetings. No formal presentation will be made. Qualified investors who would like to register for the conference can contact Vince Curatola, Director of Corporate Marketing Services at firstname.lastname@example.org.
About Assure Holdings
Assure Holdings Corp. is a best-in-class provider of outsourced intraoperative neuromonitoring and remote neurology services. The Company delivers a turnkey suite of clinical and operational services to support surgeons and medical facilities during invasive procedures that place the nervous system at risk including neurosurgery, spine, cardiovascular, orthopedic and ear, nose and throat surgeries. Assure employs highly trained technologists that provide a direct point of contact in the operating room. Physicians employed through Assure subsidiaries simultaneously monitor the functional integrity of patients’ neural structures throughout the procedure communicating in real-time with the surgeon and technologist. Accredited by The Joint Commission, Assure’s mission is to provide exceptional surgical care and a positive patient experience. For more information, visit the company’s website at www.assureneuromonitoring.com.
This news release may contain “forward-looking statements” within the meaning of applicable securities laws, including, but not limited to comments with respect to: expectations with respect to the Company’s growth and development and the quality and results of future services. Forward-looking statements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to: the uncertainty surrounding the spread of COVID-19 and the impact it will have on the Company’s operations and business, its remote neurology business, and economic activity in general; and risks and uncertainties discussed in our most recent annual and quarterly reports filed with the United States Securities and Exchange Commission, including our annual report on Form 10-K filed on March 14, 2022, and available on the Company’s EDGAR profile at www.sec.gov, which risks and uncertainties are incorporated herein by reference. Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.
Scott Kozak, Investor and Media Relations
Assure Holdings Corp.
Released May 17, 2022